Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Zimmer Hopes To Put Durom Hip Implant Suspension Behind It By Year-End

This article was originally published in The Gray Sheet

Executive Summary

Zimmer expects to update the labeling of its suspended Durom Cup metal-on-metal hip implant over the next several weeks, paving the way for a full reintroduction of the product into the U.S. market by 2009, the firm announced July 22

You may also be interested in...



Physician-Initiated Alert Sparks Zimmer Investigation Of Durom Hip Failures

Zimmer is investigating failures of its Durom hip implants after a prominent joint reconstruction surgeon sent a letter reporting a series of problems with the device to the American Association of Hip and Knee Surgeons

Zimmer Announces Comprehensive Compliance Reform Program

Zimmer says its new comprehensive compliance policy will change how the company invests its marketing and research budgets, but will not hinder its ability to develop new products over the long-run

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi, Janet Woodcock’s new post-FDA role, and ongoing preparations for new pneumococcal vaccines that will reach the market soon.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT026393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel